iBio (IBIO) Revenue (2011 - 2025)

iBio (IBIO) has reported Revenue for 15 consecutive years, with $100000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Revenue changed N/A year-over-year to $100000.0 in Q3 2025; TTM through Jun 2026 was $100000.0, a 75.0% decrease from a year earlier, with the FY2026 full-year figure at $100000.0, down 75.0% from the prior year.
• Revenue was $100000.0 for Q3 2025 at iBio, down from $200000.0 in the prior quarter.
• Over five years, Revenue peaked at $1.8 million in Q1 2022 and troughed at $50000.0 in Q3 2023.
• A 5-year average of $429444.4 and a median of $200000.0 in 2024 frame the typical range for Revenue.
• The widest YoY moves for Revenue: up 696.88% in 2021, down 79.51% in 2021.
• Over 5 years, Revenue stood at $84000.0 in 2021, then surged by 2042.86% to $1.8 million in 2022, then sank by 97.22% to $50000.0 in 2023, then surged by 300.0% to $200000.0 in 2024, then slumped by 50.0% to $100000.0 in 2025.
• The last three Revenue figures came in at $100000.0 (Q3 2025), $200000.0 (Q2 2025), and $200000.0 (Q4 2024), per Business Quant data.